Venus Gains Myanmar MA For Elores

Venus Remedies has received a marketing authorisation (MA) from regulatory authorities in Myanmar for its antibiotic adjuvant entity, Elores. The company plans to launch the product in Myanmar by April.

Venus has already received patents for Elores from 46 countries. In November 2013 it also received an MA for the product from Guatemala. Venus added that registration procedures for the drug in 13 EU member states and 15 other countries, including South Korea, South Africa and Saudi Arabia, were in advanced stages. Elores was initially launched in India in January 2013.

Venus Gains Myanmar MA For Elores

Venus Remedies has received a marketing authorisation (MA) from regulatory authorities in Myanmar for its antibiotic adjuvant entity, Elores. The company plans to launch the product in Myanmar by April.

Venus has already received patents for Elores from 46 countries. In November 2013 it also received an MA for the product from Guatemala. Venus added that registration procedures for the drug in 13 EU member states and 15 other countries, including South Korea, South Africa and Saudi Arabia, were in advanced stages. Elores was initially launched in India in January 2013.

×

Enter your details to read the full article

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

×

REQUEST A DEMO

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

Thank you for your interest

A member of the team will be in touch shortly to arrange a convenient time for your free demonstration and trial. If your enquiry is urgent, please email our Client Services team here.